![]() |
|
|
Program in Cellular and Molecular Biosciences, Department of Animal Sciences, Auburn University, AL 36849
2To whom correspondence should be addressed. E-mail: bergewg{at}auburn.edu.
| ABSTRACT |
|---|
|
|
|---|
KEY WORDS: lipogenesis lipolysis lipoproteins species comparisons transcription factors
In the early 21st century, humanity finds itself facing bourgeoning medical problems related to overconsumption of highly available, energy-rich foods. This human culinary behavior contributes to the onset of obesity, type 2 diabetes, and related cardiovascular maladies. Although there are emerging data pointing to increased longevity upon energy restriction in eukaryotic cell, insect, and animal models (1), unfortunately for most overweight individuals, voluntary reductions in dietary energy intake and needed lifestyle changes are difficult to maintain for sustained periods of time. This emerging or present obesity crisis has prompted initiation of extensive research efforts in areas such as eating behavior, appetite control, and food intake regulation as well as in regulation of lipid metabolism, cardiovascular function, endocrine function, and dyslipidemia states utilizing various animal models and cell culture systems. This review will summarize various interspecies differences in lipid metabolism that may have to be considered when evaluating research findings from various animal models for application to human biology.
Comparative Lipid Biology: an Overview. Various animal species have been used to exploit their physiological uniqueness in addressing biomedical research issues, but too often differences in lipid biology between animal species and humans are not adequately considered in experimental designs. The availability of various animal models, in particular gene knockout and transgenic rodents, can make explorations of the role or function of a given or set of genes experimentally relatively straightforward and extremely useful in identifying gene level relations between atherosclerosis and associated maladies (2). The question that is often not addressed, however, is how data obtained with the "rodent model" apply to actual physiological/clinical settings in humans? In addition, there are numerous animal species that provide recreation or food to humans. Many key aspects of lipid metabolism in these species are not identical to rodents, but their lipid biology has been studied not only from a biomedical perspective but also to apply such knowledge to agricultural production and animal health. For example, domestic pigs, because of their similarity to humans in body size and other physiological/anatomical features, including their innate tendency to overconsume food, have been used to study multiple aspects of atherosclerosis and cardiovascular disease (CVD)4 (3). In humans, obesity and CVD are typically associated with chronic, high-fat, excess energy consumption but domesticated pigs, although omnivores (4) in wild settings, consume a very carbohydrate-rich diet. In pigs, feeding a high-fat cholesterol diet results in the onset of atherosclerosis-like symptoms, which is of real benefit in experimental protocols in which the emphasis is on disease progression and pathogenesis (5,6).
Sites of De Novo Synthesis of Fatty Acids and Principal Carbon Source in Animal Species. Although liver, adipose tissue, mammary gland, and intramuscular fat depots have the capacity for de novo lipogenesis (DNL) (79), lipogenesis, cholesterol synthesis, lipoprotein synthesis and export, and fatty acid oxidation have been investigated primarily in rodent liver (810). Except in avian species in which DNL occurs in the liver (7,11), DNL in many other animals is centered in the adipose tissues. In addition, although glucose is the principal carbon source for DNL in some species, acetic acid serves as the precursor for DNL in many other species. Use of acetate as substrate eliminates or modifies the role of glucose transporters and carbohydrate-specific transacting factors, such as carbohydrate responsive element binding protein (12) in the regulation of lipid metabolism. Table 1 presents a comparison of site of de novo lipogenesis (DNL) and carbon precursor sources in humans, rodents, and various other species. For dogs, cats, pigs, cattle, sheep, and goats, DNL is centered in adipose tissues (1316), whereas in humans and rodents, the liver is the primary site for DNL (79). Significantly, in animals with extensive forestomach and hindgut fermentations such as rabbits, cattle, sheep, and goats, a digestive tract fermentation end product, acetic acid, is the principal precursor for DNL (16). In addition, in species that do not metabolize glucose particularly well, e.g., cats, which are carnivores (17), acetate appears to be the principal precursor for DNL (14). Figure 1 depicts the pathways for DNL in utilizers of glucose and acetate irrespective of tissue specificity. A principal difference between glucose utilizers and acetate utilizers is the path for fatty acid precursor carbon flow; in glucose utilizers, carbon flow is routed through the mitochondria, whereas in acetate utilizers, acetate is activated directly in the cytosol (Fig 1). There appear to be no other differences in the process of fatty acid synthesis, e.g., the roles of cytosolic acetyl CoA carboxylase and fatty acid synthase are similar among all species.
|
|
Adipocytes from most mammalian species respond to ßAR agonists quite well, with the most profound effects demonstrable on stimulation of catabolic lipid metabolism, i.e., lipolysis; the anabolic pathways are generally inhibited (19,23). Three subtypes of ß-adrenergic receptors (ß1 AR, ß2 AR, and ß3 AR) are usually observed in adipocytes. However, the subtype distribution in various tissues, including the adipocyte, is species specific; the predominant rodent adipocyte receptor is the ß3 AR (
90%), whereas in most other species, this subtype is present in very small numbers in adipocytes (usually
10%). Thus, the rodent adipocyte is controlled primarily by ß3 AR, whereas this is not true in most other mammals (24). Furthermore, the primary structure of the ßAR subtypes varies with the species, potentially imparting species specificity for responses to synthetic ßAR agonists and antagonists. For example, there is considerable stringency for the agonists and antagonists to stimulate or inhibit ßAR in pigs, whereas the rodent ßARs are stimulated or inhibited by a broad range of agonists and antagonists (24). The
-adrenergic receptors, particularly the
2-receptors, work in opposition to the ßAR, e.g., they inhibit lipolysis. In some species such as rats and pigs, the
2-adrenergic receptor function is difficult to demonstrate; in adipose tissue from other species, including humans,
2-adrenergic inhibition is marked (25).
Effects of Dietary Fatty Acids on Fatty Acid Synthesis. De novo fatty acid synthesis is inhibited by nonesterified long-chain fatty acids [NEFA (26,27)] and cytosolic acetyl-CoA carboxylase activity is sensitive to feedback inhibition from long-chain fatty acyl CoA in rodent liver (28). PUFA are particularly effective inhibitors of rodent hepatic fatty acid synthesis, whereas saturated NEFA have a lesser effect (26,27); a somewhat similar pattern is observed in rodent adipose tissue (26,29). These effects of PUFA are due largely to a reduction of mRNA for lipogenic enzymes at the transcription level (26,27). In contrast, in pigs with little hepatic DNL, adipose tissue DNL is inhibited by feeding fats containing predominantly saturated or unsaturated fatty acids (30); in one study (31), palmitic acid was 23 times as effective as linoleic acid. Ruminants do not respond well to supplemental dietary lipids in excess of 5% dietary dry matter because fatty acids interfere with reticulo-rumen anaerobic microbial digestive activity. Dietary fatty acids may be shunted to the small intestine in ruminants by feeding rumen-protected lipids such as whole cottonseeds and fatty acid-calcium salts (32,33). Under such conditions, supplemental fatty acids reduced DNL in adipose tissues and mammary glands of dairy cows (32,33).
During the last decade, there has been considerable interest in conjugated linoleic acids (CLAs), 18-carbon fatty acid analogs of linoleic acid (34). The 2 double bonds in linoleic acid are cis-9, cis-12, whereas the common CLA isomers studied are cis-9, trans-11, and trans-10, cis-12. Feeding of large amounts of CLA to various species decreases adipose deposition of fat, but in mice, this may be accompanied by increased lipid accumulation in the liver; the 10,12-CLA isomer is the active form for most of these effects (34). In mice or in rodent clonal adipocytes in culture, CLA increases metabolic rate and fatty acid oxidation, and decreases adipocyte hyperplasia and differentiation, fatty acid synthesis, lipoprotein lipase, and stearoyl CoA desaturase (34,35). Decreased fat deposition is observed in other species, but the effects, including those in rats, are not as striking as in mice (35,36). Also, many of the potential mechanisms for decreased fat deposition observed in mice are difficult to demonstrate in other species or are inconsistent (35). In ruminant species, the 9,11- and, to a lesser extent, 10,12-CLA isomers are produced during ruminal biohydrogenation of dietary PUFA and subsequent desaturation in various tissues, resulting in some deposition of CLA isomers in meat and milk from ruminant species (37). The 10,12-CLA isomer was causally linked with the milk fat depression syndrome in lactating cows fed low-fiber, high-cereal grain diets (37). The 10,12-CLA isomer has now been shown to suppress expression of mammary fatty acid synthase by attenuating sterol regulatory element binding protein-1c (SREBP-1c) expression and proteolytic processing (38). The effects of CLA in humans are marginal and difficult to demonstrate, perhaps because much lower levels were fed than in experimental animals.
Role of Transcription Factors in Lipid Metabolism. The transcription factor SREBP-1c (or ADD1) has an important role in the control of fatty acid synthase expression (10). The most definitive data on the regulatory role of SREBP-1c in lipogenesis arise from SREBP-1c null mice, SREBP-1c overexpression, and negative-dominant SREBP-1c expression studies in rodents (10), but such data are lacking for most species (11). Typically SREBP-1c and fatty acid synthase (FAS) genes are both expressed and correlated in tissues that synthesize fatty acids de novo (11). Thus, in chicken liver, SREBP-1c and FAS transcripts and proteins are elevated coordinately (7), whereas in pigs, SREBP-1c and FAS transcripts and DNL are elevated in adipose tissue (11). In pigs, after feeding a commercial ß-adrenergic agonist for >2 wk, adipose expression of both FAS and SREBP-1 were attenuated in parallel (39). In contrast, other findings, indicated that although adipocyte lipogenesis is highly correlated with insulin status (9), SREBP-1c mRNA abundance does not always coincide with lipogenic activity (40).
It is generally considered that the transcription factor, peroxisomal proliferator-activated receptor
(PPAR
) controls the expression of fatty acid oxidative metabolism by modulating the expression of peroxisomal acyl CoA oxidase and mitochondrial carnitine palmitoyltransferase (41). This transcription factor and these enzymes are highly expressed in rodent liver and to only a modest extent in adipose tissue, giving rise to the concept that adipose tissue does not oxidize fatty acids to any extent. In pigs, there appears to be greater expression of PPAR
transcripts in adipose tissue than in liver (42,43), suggesting that in this species, and perhaps in other mammals as well, adipose tissue may oxidize sizeable quantities of fatty acids. Sundvold et al. (44), however, could not demonstrate PPAR
expression in porcine adipose tissues in their extensive work. PPAR
is expressed in skeletal muscle; when activated, for example, by a fatty acid ligand, it promotes fatty acid oxidation, ketone body synthesis, and glucose sparing (41).
Comparative Aspects of Lipoproteins and Lipid Trafficking. Lipids are transported in the blood plasma as lipoproteins, complexes of various lipid materials with specific proteins. The large chylomicron and VLDL contain considerable amounts of triacylglycerol with small amounts of cholesterol. Chylomicrons are synthesized in the intestine and are found in lymph and in plasma after a meal containing fat (45,46). Ruminant species have few or no chylomicron particles because consumption of fats > 5% diet dry matter interferes with the rumen microbial feed digestion; under such circumstances, few long-chain fatty acids are absorbed (45). The LDL and HDL are the predominant carriers of cholesterol. Species differ in the proportion of the plasma cholesterol-containing lipoprotein, LDL and HDL (46,47). Guinea pigs, pigs, rabbits, and sheep transport most of the cholesterol in LDL, as do humans. Many potential animal models, in particular rodents, carry the majority of cholesterol in HDL rather than LDL, making them less than desirable as models. Pigs have been a useful model for human atherogenesis, not only because of many similarities in the lipoproteins, but also because it is an omnivorous species, as are humans (4).
Coda.
This short review provides evidence from the rich literature on comparative lipid metabolism that many differences in lipid biology exist among species. Workers must be cognizant of such differences whenever applying their results from various animal models to humans. This point is amplified in a recent report on novel mechanisms of PPAR
activation (48) in which the authors state, "In mammals, the liver integrates nutrient intake and delivery of carbohydrate and lipids to peripheral tissues." Clearly this is not correct for all mammals.
| FOOTNOTES |
|---|
3 Retired; formerly with U.S. Department of Agriculture, Agricultural Research Service-Childrens Nutrition Research Center, Department of Pediatrics, Baylor College of Medicine, Houston, TX 77030. ![]()
4 Abbreviations used: ßAR, ß-adrenergic receptor; CVD, cardiovascular disease; CLA, conjugated linoleic acid; DNL, de novo lipogenesis; FAS, fatty acid synthase; NEFA, nonesterified long-chain fatty acids; PPAR
, peroxisomal proliferatoractivated receptor
; SREBP-1c, sterol regulatory element binding protein-1c. ![]()
| LITERATURE CITED |
|---|
|
|
|---|
1. Smith JV, Heilbronn LK, Ravussin E. Energy restriction and aging. Curr Opin Clin Nutr Metab Care. 2005;7:615-622.
2. Swanson KS, Mazur MJ, Vashisht K, Rund LA, Beever JE, Counter CM, Schook LB. Genomics and clinical medicine: rationale for creating and effectively evaluating animal models. Exp Biol Med. 2004;229:866-875.
3. Gootman PM. Cardiovascular system. Pond WG Mersmann HJ eds. Cardiovascular system. Biology of the domestic pig. :533-559 Cornell University Press Ithaca.
4. Mersmann HJ. The pig: a concise source of information. Stanton HC Mersmann HJ eds. The pig: a concise source of information. Swine in cardiovascular research. :1-9 CRC Press Boca Raton.
5. Pond WG. Nutrition and the cardiovascular system of swine. HC Stanton HJ Mersmann eds. Nutrition and the cardiovascular system of swine. Swine in cardiovascular research. 1986;Vol II:1-31 CRC Press Boca Raton.
6. Pond WG, Mersmann HJ. Genetically diverse pig models in nutrition research related to lipoprotein and cholesterol metabolism. Tumbleson ME Schook LB eds. Genetically diverse pig models in nutrition research related to lipoprotein and cholesterol metabolism. Advances in swine in biomedical research. :843-863 Plenum Press New York.
7. Hillgartner FB, Salati LS, Goodridge AG. Physiological and molecular mechanisms involved in nutritional regulation of fatty acid synthesis. Physiol Rev. 1995;75:47-76.
8. Sul HS, Wang D. Nutritional and hormonal regulation of enzymes in fat synthesis: studies of fatty acid synthase and mitochondrial glycerol-3-phosphate acyltransferase gene transcription. Annu Rev Nutr. 1998;18:331-351.[Medline]
9. Bernlohr DA, Jenkins AE, Bennars AA. (2002) Adipose tissue metabolism and lipid metabolism. Vance DE Vance JE eds. (2002) Adipose tissue metabolism and lipid metabolism. Biochemistry of lipids, lipoproteins and membranes. 4th ed. :263-289 Elsevier Amsterdam.
10. Horton JD, Goldstein JL, Brown MS. SREBPs: activators of the complete program for cholesterol and fatty acid synthesis in liver. J Clin Invest. 2002;109:1125-1131.[Medline]
11. Gondret F, Ferre P, Dugail I. ADD-1/SREBP-1 is a major determinant of tissue differential lipogenic capacity in mammalian and avian species. J Lipid Res. 2001;42:106-113.
12. Dentin R, Girad J, Postic C. Carbohydrate responsive element binding protein (ChREBP) and sterol regulatory element binding protein-1c (SREBP-1c): two key regulators of glucose metabolism and lipid synthesis in liver. Biochimie. 2005;87:81-86.[Medline]
13. Baldner GL, Flatt RE, Shaw RN, Beitz DC. Fatty acid biosynthesis in liver and adipose tissue from dogs. Comp Biochem Physiol B. 1985;82:153-156.[Medline]
14. Richard MJ, Holck JT, Beitz DC. Lipogenesis in liver and adipose tissue of the domestic cat (Felis domestica). Comp Biochem Physiol B. 1989;93:561-564.[Medline]
15. Mersmann HJ, Houk JM, Phinney G, Underwood MC, Brown LJ. Lipogenesis by in vitro liver and adipose tissue preparations from neonatal swine. Am J Physiol. 1973;224:1123-1129.
16. Vernon RG. Lipid metabolism in the adipose of ruminant animals. Prog Lipid Res. 1980;19:23-106.[Medline]
17. Young KM, Walker SL, Lanthier C, Wadell WT, Momfort SL, Brown JL. Noninvasive monitoring of adrenocortical activity in carnivores by fecal glucocorticoid analyses. Gen Comp Endocrinol. 2004;137:148-165.[Medline]
18. Rudman D, DiGorolamo M. Comparative studies in the physiology of adipose tissues. Adv Lipid Res. 1967;5:35-117.[Medline]
19. Vernon RG, Clegg RA. The metabolism of white adipose tissue in vivo and in vitro. Cryer A Van RLR eds. The metabolism of white adipose tissue in vivo and in vitro. New perspectives in adipose tissue: structure, function and development. :65-86 Butterworths London.
20. Hoffman BB. Catecholamines, asympathomimetic drugs, and adrenergic receptor antagonists. Hardman JG Limbird LE eds. Catecholamines, asympathomimetic drugs, and adrenergic receptor antagonists. The pharmacological basis of therapeutics. 10th ed. :210-268 McGraw-Hill New York.
21. DiGorolamo M, Rudman D. Species differences in glucose metabolism and insulin responsiveness of adipose tissue. Am J Physiol. 1966;210:721-727.
22. Smith SB, Prior R.L., Mersmann HJ. Interrelationships between insulin and lipid metabolism in normal and alloxan-diabetic cattle. J Nutr. 1983;113:1002-1015.
23. Mersmann HJ. Regulation of adipose tissue metabolism and accretion in mammals raised for meat production. Pearson AM Dutson TR eds. Regulation of adipose tissue metabolism and accretion in mammals raised for meat production. Advances in meat research, growth regulation in farm animals. 1991;Vol 7:135-168 Elsevier Applied Sciences London.
24. Mersmann HJ. Species variation in mechanisms for modulation of growth by ß-adrenergic receptors. J Nutr. 1995;125:1777S-17782.
25. Mersmann HJ. Absence of
adrenergic inhibition of lipolysis in swine adipose tissue. Comp Biochem Physiol. 1984;79C:165-170.
26. Wahle KWJ, Rotondo D, Heys SD. Polyunsaturated fatty acids and gene expression in mammalian systems. Proc Nutr Soc. 2003;62:349-360.[Medline]
27. Jump DB. Fatty acid regulation of gene transcription. Crit Rev Clin Lab Sci. 2004;41:41-78.[Medline]
28. Voet D, Voet JG. Fatty acid regulation of gene transcription. Biochemistry. 3rd ed. John Wiley & Sons Somerset.
29. Duplus E, Forest C. Is there a single mechanism for fatty acid regulation of gene transcription?. Biochem Pharmacol. 2002;64:893-901.[Medline]
30. Allee GL, Romsos DR, Leveille GA, Baker DH. Lipogenesis and enzymatic activity in pig adipose tissue as influenced by source of dietary fat. J Anim Sci. 1972;35:41-47.
31. Smith DR, Knabe DA, Smith SB. Depression of lipogenesis in swine adipose tissue by specific fatty acids. J Anim Sci. 1996;74:975-983.[Abstract]
32. Cummins KA, Russel RW. Effects of feeding whole cottonseed to lactating dairy cows on glucose and palmitate metabolism. J Dairy Sci. 1985;68:2009-2015.
33. McNamara JP, Harrison JH, Kincaid RL, Waltner SS. Lipid metabolism in adipose tissue of cows fed high fat diets during lactation. J Dairy Sci. 1995;78:2782-2796.[Abstract]
34. Wahle KWJ, Stevens SD, Rotondo D. Conjugated linoleic acids: are they beneficial or detrimental to health?. Prog Lipid Res. 2004;43:553-587.[Medline]
35. Mersmann HJ. Mechanisms for conjugated linoleic acid-mediated reduction in fat deposition. J Anim Sci. 2002;80(Suppl. 2):E126-E134.
36. Kang K, Miyasaki M, Ntambi JM, Pariza MW. Evidence that the anti-obesity effect of conjugated linoleic acid is independent of effects on stearoyl-CoA desaturase 1 expression and enzyme activity. Biochem Biophys Res Commun. 2004;315:532-537.[Medline]
37. Bauman DE, Griinari JM. Nutritional regulation of milk fat synthesis. Annu Rev Nutr. 2003;23:203-227.[Medline]
38. Peterson DG, Matitashvili EA, Bauman DE. The inhibitory effect of trans-10, cis-12 CLA on lipid synthesis in bovine mammary epithelial cells involves reduced proteolytic activation of the transcription factor SREBP-1. J Nutr. 2004;134:2523-2527.
39. Halsey CHC. The inhibitory effect of trans-10, cis-12 CLA on lipid synthesis in bovine mammary epithelial cells involves reduced proteolytic activation of the transcription factor SREBP-1. The effect of the cAMP-elevating agent Paylean on the transcriptional control of lipogenesis and lipid oxidation in swine [MS thesis]. :142 Auburn University Auburn (AL).
40. Bertile F, Raclot T. mRNA levels of SREBP-1c do not coincide with the changes in adipose lipogenic gene expression. Biochem Biophys Res Commun. 2004;325:827-834.[Medline]
41. Ferre P. The biology of peroxisomal proliferator-activated receptors: a relationship with lipid metabolism and insulin sensitivity. Diabetes. 2004;53:S43-S50.
42. Ding S-T, Schinckel AP, Weber TE, Mersmann HJ. Expression of porcine transcription factors and genes related to fatty acid metabolism in different tissues and genetic populations. J Anim Sci. 2000;78:2127-2134.
43. Ajuwon KM, Kuske JL, Anderson DB, Hancock DL, Houseknecht KL, Adeola O, Spurlock ME. Chronic leptin administration increases serum NEFA in the pig and differentially regulates PPAR expression in adipose tissue. J Nutr Biochem. 2003;14:576-583.[Medline]
44. Sundvold H, Grindflek E, Lien S. Tissue distribution of porcine peroxisomal proliferator-activated receptor
: detection of an alternatively spliced mRNA. Gene. 2001;273:105-113.[Medline]
45. Drackley JK. Interorgan lipid and fatty acid metabolism in growing ruminants. Burrin DG Mersmann HJ eds. Interorgan lipid and fatty acid metabolism in growing ruminants. Biology of metabolism in growing animals. :323-350 Elsevier Edinburgh.
46. Vitac J, Stevanovic J. Comparative studies of serum lipoproteins and lipids in some domestic, laboratory and wild animals. Comp Biochem Physiol. 1993;106B:223-229.
47. Mersmann HJ, Pond WG. Hematology and blood serum constituents. Pond WG Mersmann HJ eds. Hematology and blood serum constituents. Biology of the domestic pig. :560-584 Cornell University Press Ithaca.
48. Chakravarthy MV, Pan Z, Zhu Y, Tordjman K, Schneider JG, Coleman T, Turk J, Semenkovich F. "New" hepatic fat activates PPAR
to maintain glucose, lipid, and cholesterol homeostasis. Cell Metab. 2005;1:309-322.[Medline]
This article has been cited by other articles:
![]() |
C. H. Chen, P. H. Wang, B. H. Liu, H. H. Hsu, H. J. Mersmann, and S. T. Ding Serum Amyloid A Protein Regulates the Expression of Porcine Genes Related to Lipid Metabolism J. Nutr., April 1, 2008; 138(4): 674 - 679. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. A. Cummins, S. G. Solaiman, and W. G. Bergen The effect of dietary copper supplementation on fatty acid profile and oxidative stability of adipose depots in Boer x Spanish goats J Anim Sci, February 1, 2008; 86(2): 390 - 396. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Levy, K. Trudel, M. Bendayan, E. Seidman, E. Delvin, M. Elchebly, J.-C. Lavoie, L.-P. Precourt, D. Amre, and D. Sinnett Biological role, protein expression, subcellular localization, and oxidative stress response of paraoxonase 2 in the intestine of humans and rats Am J Physiol Gastrointest Liver Physiol, December 1, 2007; 293(6): G1252 - G1261. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. J. G. C. van den Borne, G. E. Lobley, M. W. A. Verstegen, J.-M. Muijlaert, S. J. J. Alferink, and W. J. J. Gerrits Body Fat Deposition Does Not Originate from Carbohydrates in Milk-Fed Calves J. Nutr., October 1, 2007; 137(10): 2234 - 2241. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Gagne, S. Crane, Z. Huang, C. S. Li, K. P. Bateman, and J.-F. Levesque Rapid measurement of deuterium-labeled long-chain fatty acids in plasma by HPLC-ESI-MS J. Lipid Res., January 1, 2007; 48(1): 252 - 259. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. C. Veltri, R. C. Backus, Q. R. Rogers, and E. J. DePeters Adipose Fatty Acid Composition and Rate of Incorporation of {alpha}-Linolenic Acid Differ between Normal and Lipoprotein Lipase-Deficient Cats J. Nutr., December 1, 2006; 136(12): 2980 - 2986. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||